International Biomedical Research Alliance
Nonprofit profile at a glance
- EIN
- 203382296
- IRS 990 coverage
- 2017–2024
- Forms available
- Form 990 2024
- Location
- Washington, DC, USA
- Phone
- 7714441353
- Rating
- 76
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Medical Research N.E.C.
Reported finances
- Revenue
- $292,601
- Expenses
- $547,432
- Assets
- $114,478
- Liabilities
- $45,301
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
18 people listed
Executive titles in this filing
- AUSTIN SWAFFORD PHD (PRESIDENT)
Highest reported compensation
- AUSTIN SWAFFORD PHD (PRESIDENT): $140,000 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Our mission is to invest in and accelerate the development of the most promising future leaders in biomedical research with global impact.
What it reported doing in 2024
The international biomedical research alliance advances the training and career development of future leaders in biomedical research through scholarships, mentorship, and professional development programs. In 2024, ibra supported more than 40 active participants with research and leadership training, delivered over 30 days of professional development programming, and engaged nearly 400 alumni and current scholars representing more than 185 universities across 9 countries.ibra expanded its programming in 2024 to strengthen professional networks and leadership pathways for early-career researchers. Activities included alumni mentorship initiatives, collaborative workshops, and sector-spanning career development programs connecting academia, industry, and investment communities. These efforts broadened ibra's impact beyond doctoral training, supporting a global community of biomedical professionals committed to advancing treatments and cures for human disease.ibra provides leadership development and professional skills training to strengthen the capacity of early-career biomedical researchers. In 2024, the organization delivered over a dozen structured workshops and training events covering topics such as research ethics, scientific communication, entrepreneurship, and translational medicine, directly benefiting both current scholars and alumni.ibra fosters a global biomedical research community through alumni engagement and collaborative networking programs. In 2024, ibra supported mentoring relationships across its network of nearly 400 alumni and facilitated professional connections spanning academia, industry, and investment sectors, broadening opportunities for collaboration and career advancement.
Operating model
- Revenue model
- Donor-supported. 95% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 86% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
- Includes noncash contributions: Reported contributions include donated property or goods.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. The filing reports few safeguards for money sent abroad and fundraising costs are high for each dollar raised.
Rating breakdown
- Financial Efficiency: 80
- Transparency & Controls: 75
- Accountability: 84
- Sustainability: 8
- Growth: 80
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 64.9%; rating input score 65
- Fundraising efficiency: $5.42 raised per $1 spent on fundraising; rating input score 24; 24th percentile among comparable filings
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Scored; rating input score 0
- Grant itemization coverage: 100%; rating input score 100; 80th percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
- Governance controls: 5 of 8 controls in place; rating input score 62
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Fail
- Board meeting minutes documented: Pass
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: -87.1%; rating input score 3; 3rd percentile among comparable filings
- Total-asset coverage ratio: 0.21; rating input score 12; 12th percentile among comparable filings
- Liabilities to assets ratio: 0.4; rating input score 13; 13th percentile among comparable filings
- Officer compensation ratio: 25.6%; rating input score 14; 14th percentile among comparable filings
Growth
- Program expense growth: 19.8% per year; rating input score 100; 84th percentile among comparable filings
- Revenue growth: 7.4% per year; rating input score 100; 63rd percentile among comparable filings
- Asset growth: -0.3% per year; rating input score 0; 24th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 64.9% of spending went to programs
- Governance: 16 of 16 board members independent · 5 of 8 filing controls reported
- Programs: 1 filed program accomplishment · $356K in reported program spending
- Leadership: top reported pay $140K · 18 people listed
- Consistency: 28 of 28 current checks pass
- Schedules: 6 filed schedules · includes major donors, foreign activity, and grants
- Filing history: 8 filing years from 2017 to 2024
- Contacts: How to reach this organization
- Money network: 1 filed money-flow record
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Foreign activity oversight scored 0/100.
- High — Financial Efficiency: Fundraising efficiency scored 24/100.
- Review — Accountability: Governance controls: 2 of 7 not reported.
- High — Sustainability: Operating margin scored 3/100.
- High — Sustainability: Total-asset coverage ratio scored 12/100.
- High — Growth: Asset growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 13/100.
- High — Sustainability: Officer compensation ratio scored 14/100.